OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas
NCT01052363
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
No funding
Conditions
Central Nervous System Tumors
Interventions
DRUG:
Bevacizumab, CA4P
Sponsor
West Virginia University